Article By:
Zacks Investment Research
Saturday, October 2, 2021 3:14 PM EDT
The biotechnology sector has been grabbing the headlines on the new coronavirus vaccine and drug-related updates. The space has also kept its promise of generating returns, with the Nasdaq Biotechnology Index rising about 6.9% so far in 2021.